Unresolved discrepancies between cannabinoid test results for infant urine

Clinical Chemistry

Volumn 58, Issue 9, 2012, Pages 1364-1367

  Barakauskas, Vilte E ^a   Davis, Rebecka ^b   Krasowski, Matthew D ^c   McMillin, Gwendolyn A ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 HYDROXYDRONABINOL; CANNABINOID; TETRAHYDROCANNABINOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG EXPOSURE; DRUG SCREENING; HOSPITAL LABORATORY; HUMAN; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; MECONIUM; NEWBORN; URINALYSIS;

CANNABINOIDS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MATERNAL EXPOSURE; PREGNANCY; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84865713446     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.190090     Document Type: Article

References (9)

1. Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers 2007;4:1770-804.
2. Nagata T, Takahashi Y, Ishii Y, Asai S, Sugahara M, Nishida Y, et al. Profiling of genes differentially expressed between fetal liver and postnatal liver using high-density oligonucleotide DNA array. Int J Mol Med 2003;11:713-21.
3. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 1999;37:485-505.
4. Leeder JS. Pharmacogenetics, pharmacogenomics, and pharmacoproteomics. In: Yaffe SJ, Aranda JV, eds. Neonatal and pediatric pharmacology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p 44-59.
5. Rane A. Drug metabolism and disposition in infants and children. In: Yaffe SJ, Aranda JV, eds. Neonatal and pediatric pharmacology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p 32-43.
6. Cotten SW, Duncan DL, Burch EA, Seashore CJ, Hammett-Stabler CA. Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay. Clin Biochem 2012;45:605-9.
7. ElSohly MA, Feng S. Δ9-THC metabolites in meconium: identification of 11-OH-Δ9-THC, 8β,11-diOH-Δ9-THC, and 11-nor-Δ9-THC-9- COOH as major metabolites of Δ9-THC. J Anal Toxicol 1998;22:329-35.
8. Gray TR, Barnes AJ, Huestis MA. Effect of hydrolysis on identifying prenatal cannabis exposure. Anal Bioanal Chem 2010;397:2335-47.
9. Coles R, Clements TT, Nelson GJ, McMillin GA, Urry FM. Simultaneous analysis of the Δ9-THC metabolites 11-nor-9-carboxy-Δ9-THC and 11-hydroxy-Δ9-THC in meconium by GC-MS. J Anal Toxicol 2005;29:522-7.